Found 46 matching trials
Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients
PHASE2To evaluate the efficacy and safety of CAGM regimen in R/R DLBCL patients a...
Location
the First Affiliated Hospital of Soochow University
Clinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
PHASE2The purpose of this study is to evaluate the efficacy and safety of venetoc...
Location
Chinese PLA General Hospital
The Efficacy of CAPCT in Patients With PTCL
PHASE2This study is a multicenter, single-arm, non-randomized, open-label trial d...
Location
The First Affiliated Hospital of Nanjing Medical University
Biomarker Guided Treatment in DLBCL
PHASE2This study is to investigate the strategy of biomarker guided treatment in ...
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
PHASE2ETP-ALL like patients have poor outcomes and prognosis, and the optimal the...
Location
The First Affiliated Hospital of Soochow University
Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy
PHASE2This prospective, open-label, single-arm study will evaluate the efficacy a...
Location
Shanghai Ruijin Hospital
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia
PHASE2The purpose of this study is to compare the efficacy and safety of venetocl...
Location
Chinese PLA General Hospital
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
PHASE2The purpose of this study is to compare the efficacy and safety of venetocl...
Location
Chinese PLA General Hospital
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE2This study is to investigate the therapeutic efficacy and side effect of ch...
Status
Active Not Recruiting
Location
The First Affliated Hospital of Soochow University
Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML
PHASE2This study aims to explore a superior first-line induction remission regime...
Location
Multiple Locations